Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 1035Neoplasms 813Carcinoma, Non-Small-Cell Lung 796Prostatic Neoplasms 617Colorectal Neoplasms 533Lung Neoplasms 478Neoplasm Metastasis 434Multiple Myeloma 394Leukemia, Myeloid, Acute 380Ovarian Neoplasms 333Pancreatic Neoplasms 316Melanoma 293Squamous Cell Carcinoma of Head and Neck 266Recurrence 260Carcinoma, Hepatocellular 248Glioblastoma 237Brain Neoplasms 236Triple Negative Breast Neoplasms 213Head and Neck Neoplasms 210Carcinoma, Renal Cell 207Precursor Cell Lymphoblastic Leukemia-Lymphoma 203Lymphoma 198Stomach Neoplasms 197Endometrial Neoplasms 190Uterine Cervical Neoplasms 182Lymphoma, Non-Hodgkin 182Sarcoma 180Glioma 179Lymphoma, Large B-Cell, Diffuse 166Hematologic Neoplasms 162

Interventions

oprelvekin 1Interleukin-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × CTIT: Cancer Therapy Induced Thrombocytopenia × 90 days × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡